GERD Linked to Increased Incidence of Pulmonary Disease
By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 19, 2025 -- The presence of gastroesophageal reflux disease (GERD) is associated with an increased incidence of pulmonary diseases, but this effect may be attenuated with GERD treatment, according to research published online July 22 in Frontiers in Cell and Developmental Biology.
Xin Wang, from Sichuan University in Chengdu, China, and colleagues conducted a meta-analysis to determine whether GERD is associated with an increased incidence of subsequent pulmonary diseases. Asthma and pneumonia were examined as the primary outcomes. Forty-five cohort studies were included in the analyses.
The researchers found that GERD was significantly linked to an increased incidence of asthma and pneumonia (odds ratios, 1.50 and 1.53, respectively), as well as pulmonary fibrosis, chronic obstructive pulmonary disease, lung cancer, interstitial lung disease, bronchiectasis, bronchitis, acute lung injury, pulmonary embolism, pulmonary tuberculosis, and nontuberculous mycobacterial pulmonary disease (odds ratios, 1.43, 1.41, 1.51, 1.28, 1.63, 1.24, 2.07, 1.33, 1.63, and 3.36, respectively). Similar results were seen in subgroup analyses stratified by age and source of odds ratio. No significant associations were seen between treated GERD and the incidence of asthma or lung cancer.
"These findings indicate the importance of screening and management for pulmonary diseases and standardized therapy in patients with GERD," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-20 06:00
Read more

- Sobi Announces U.S. Food and Drug Administration Approves Doptelet (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
- FDA Requiring Stronger Safety Labels for Opioid Medications
- Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes
- Rebound Weight Gain Common After Discontinuing Antiobesity Medications
- Gefurulimab Dual-Binding Nanobody Demonstrated Statistically Significant and Clinically Meaningful Improvement in Functional Activities of Daily Living in Adults with Generalised Myasthenia Gravis in PREVAIL Phase III Trial
- COVID-19 Vaccine Boosters Aid Outcomes in Patients With Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions